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SUMMARY
Central giant cell granuloma ( CGCG) appears to be a lesion that is unique to the jaws. 
It is difficult to predict its aggressiveness. A rare case of synchronous CGCG of the 
mandible and maxillar in a 14- year old boy is presented.
 INTRODUCTION
Central giant cell granuloma (CGCG) appears to 
be a lesion that is unique to the jaws, although the 
so-called giant cell reaction of the hands and feet 
shares many features. There is currently no way to 
predict,either clinically or microscopically, which 
lesions will behave aggressively. A case is presented 
of a 14-year-old boy who manifested synchronous 
CGCG of the right mandible and left maxilla.
 CGCG lesions in the jaws appear to follow a 
fairly benign course, but more aggressive lesions 
have been noted, particularly in the long bones. 
Though rare, aggressive giant cell lesions are locally 
invasive,destructive and vascular with a high 
recurrence rate. Their management poses an enormous 
challenge. A comprehensive history,thorough physical 
examination and biochemical and radiographic 
investigations are essential so that appropriate 
treatment is instituted. For multiple lesions that are 
resulting from endocrine causes, surgery may not be 
necessary. Surgical resection and not enucleation is 
indicated for aggressive lesions. Surgical enucleation 
is associated with high rates of recurrence in 
aggressive lesions. CGCG was formerly regarded as a 
reparative process and was accordingly called central 
giant cell reparative granuloma. Although the lession is 
not a granulomatous inflammatory process, the term 
granuloma has persisted. Many investigators believe 
that CGCG should be classified as a reactive lesion. 
Numerous documented aggressive and recurrent 
cases suggest that it may behave as a neoplasm. 
Recurrences are more likely to be seen in children 
than adults. Surgery has been the treatment of choice, 
although alternative medical therapy with calcitonin 
injections has shown some promising results in 
reducing lesions.
CASE REPORT
A 14-year-old boy presented to the maxillofacial 
department complaining of a left-sided maxillary and 
a right-sided mandibular swellings for a period of 
three months (Figure 1). The swellings were painless 
and poorly demarcated from the surrounding tissues. 
Intra orally the swellings were soft and fleshy in 
consistency. There was buccolingual expansion of the 
mandibular cortex with a perforation buccally. At the 
time of review the patient was found to have been 
severely anaemic with haemoglobin concentration 
of 6g/dl. The anaemia was iron deficiency type. 
The rest of the medical and dental history was non-
remarkable.
 Radiographic examination revealed a 
multilocular lesion involving the entire body of the 
right mandible. The maxillary lesion manifested a 
radio-opacity with saucerisation, almost resembling 
an invasive lesion with floating teeth (Figure 2). 
Incisional biopsy was performed on both lesions 
under local anaesthesia. Histopathological analysis 
revealed epithelium with normal connective tissue 
thickness and morphology overlying a connective 
tissue stroma, that had poorly defined area of 
transition into a lesion with a highly vascular and 
cellular matrix (Figure 3). These cells were fibroblasts 
with moderate mitoses and little or no pleomorphism, 
interspersed by Giant cells. The features were 
suggestive of a giant cell granuloma.
 The patient was scheduled for surgical excision 
of the mandibular and maxillary lesions after 
transfusions and haematinic therapy, followed by 
regular reviews. No further recurrence has been 
reported in the last two years and radiographic 
evaluation shows complete resolution of the lesion.
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Figure 1
Clinical photograph of the patient at presentation 
depicting a left maxillary mass
Figure 2
An orthopantomograph demonstrating right 
mandibular and left maxillary lytic lesions
Figure 3  
A photomicrograph depicting histopathologic features 
consistent with those of CGCG
DISCUSSION
CGCGs occur typically in the second and third 
decades, with a mean age of 25 years. Females are 
more frequently affected than males. CGCG has a 
predilection for the mandible,especially the body and 
anterior portions of the jaw. The lesion is radiolucent 
and usually multilocular (1,3-5). In this case the 
mandibular lesion was multilocular whereas the 
maxillary lesion was radiopaque. Resorption and or 
movement of teeth may be seen, and penetration of 
the jaw cortex may occur in aggressive lesions (3-5).
In this case there was perforation of the mandibular 
buccal cortical plate and there was mobility of the 
mandibular and maxillary teeth that were eventually 
lost in the affected quadrants. Most patients are 
asymptomatic, although pain or paresthesia may be 
a presenting complaint, particularly in aggressive 
lesions (1). Hemorrhage is usually found (1, 4, 5). 
Cells of fibroblastic origin are the dominant stromal 
cells. Mitotic figures may be frequently seen and may 
be numerous. Although they are of no prognostic 
significance, they may be confused for a malignancy 
(3,10). In in this case the lesion had been confused for 
a lymphoma  at the initial presentation.
 There are other lesions that occur in the 
jaws that contain giant cells within them. These 
include the aneurysmal bone cyst, giant cell tumor, 
hyperparathyroidism and cherubism (3, 10). Their 
relationship to each other, however, is ill-defined. 
Histologically all of the giant cell lesions appear 
identical and usually cannot be distinguished 
on light microscopy alone (3,10). This perhaps 
highlights the importance of a good clinical 
history and investigations including histology and 
immunohistochemistry in deciding the choice of 
treatment when handling these lessions. Genetic 
markers may have to be used to differentiate some 
of the lesions, even though none of the histologic 
or immunohistologic features yet described have 
allowed separation of aggressive from nonaggressive 
lesions (2, 3-,6,9). Hyperparathyroidism may be 
excluded from the diagnosis by serum calcium, 
phosphate and parathormone and parathormone-
related protein assays in all but the single small and 
more benign lesions (2,4-6,7).
 Aggressive, recurrent giant cell lesions, usually 
known as giant cell tumour (GCT) are common in the 
long bones, but not in the jaws. CGCG and GCT have 
overlapping histopathology features and, therefore, 
separation of these two lesions can be difficult. (1, 
2, 4).  The mainstay of treatment is usually surgery. 
This consists of local curettage, which is usually 
curative. There is a recurrence rate of 15-20% 1, 4. 
For lesions that are large, conservative curettage 
may result in the loss of many teeth or the inferior 
alveolar nerve in the mandible. For the aggressive 
variants, more aggressive surgery has been suggested 
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including mandibular resection and appropriate 
reconstruction (1). Complete surgical excision is a 
therapy of choice in GCT, however, others believe in 
curettage of the affected area. Excision is preferred 
over simple curettage because of the higher risk of 
recurrence without complete excision (4). A number 
of nonsurgical treatments have been tried (1, 6, 7) 
Intralesional triamcinolone injected into the lesion 
once per week for six weeks has been tried with 
some success (6,7). Their actual mode of action is 
unknown but they may work by suppressing the 
inflammatory component of the lesion. They are 
best used for smaller lesions that can be more easily 
treated by intralesional injections. Calcitonin given 
by subcutaneous injection has also been tried with 
some success though evidence is theoretical (2, 5, 8, 
9, 11). Interferon has also been utilised and acts by 
suppressing the angiogenic component of this lesion 
allowing healing to occur. Surgery is still required 
after the interferon treatment but it may be less radical 
surgery so that chances of recurrence are diminished. 
There are suggestions that the CGCG may, in fact, be 
a self healing lesion, with the natural healing process 
stimulated by the nonsurgical therapy employed (12). 
Multilocular lesions that are a result of the brown’s 
tumour of hyperparathyroidism are reported to 
resolve once the parathyroid adenoma is surgically 
removed without necessarily having to treat the jaw 
lesion ( 13, 14).
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